Ramaeker [143] showed that hypoxia can rapidly and forcefully reduce the level of UBE2T mRNA in cancer cell lines, thus greatly increasing the sensitivity of cancer cells to MMC therapy. This evidence concerns the gene UBE2T and cancer.